Bionomics Receives Notice Of Allowance For US Patent On Substituted-N-Heteroaryl Compounds For Cognitive Function And CNS Disorders
Portfolio Pulse from Benzinga Newsdesk
Bionomics has received a Notice of Allowance for a US patent on substituted-N-heteroaryl compounds, which are intended for improving cognitive function and treating CNS disorders.
August 07, 2024 | 5:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bionomics has received a Notice of Allowance for a US patent on substituted-N-heteroaryl compounds, which are intended for improving cognitive function and treating CNS disorders.
The Notice of Allowance for a US patent is a significant milestone for Bionomics, as it strengthens their intellectual property portfolio and could lead to future revenue streams from new treatments for cognitive function and CNS disorders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100